Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

ONCOLYTICS BIOTECH INC (ONCY)

55 + Investors. Track Smart Money conviction in ONCY. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↓ -5
Streak
1Q ▼
Buyers last Q
58%

Smart Money Signals — ONCY

Based on 56 hedge funds · latest filing: 2026 Q1 · updated quarterly

📉

Selling streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds reduced or closed their ONCY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.
📊

High ownership — 92% of 3.0Y peak

92% of all-time peak
56 funds currently hold this stock — 92% of the 3.0-year high of 61 funds (reached 2025 Q4). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +12% more funds vs a year ago

fund count last 6Q
+6 new funds entered over the past year (+12% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 58% buying

30 buying22 selling
Last quarter: 30 funds bought or added vs 22 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
➡️

Steady new buyers — ~14 new funds per quarter

new funds entering per quarter
Funds opening this position for the first time: 11 → 9 → 13 → 14. A stable flow of new institutional buyers suggests ongoing interest without signs of either acceleration or slowdown.
🔒

41% of holders stayed for 2+ years

41% conviction (2yr+) 30% medium 29% new
23 out of 56 hedge funds have held ONCY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
📈

Growing discovery — still being found

9 → 11 → 9 → 13 → 14 new funds/Q
New funds entering each quarter: 11 → 9 → 13 → 14. A growing number of institutions are discovering ONCY each quarter. The narrative is still spreading — leaving room for ongoing capital accumulation.
🏛️

Deep conviction — 43% of holders stayed 2+ years

43% veterans 23% 1-2yr 34% new
Of 56 current holders: 24 (43%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 17% AUM from top-100

17% from top-100 AUM funds
14 of 56 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ONCY

In 2026 Q1, 30 hedge funds were net buyers of ONCY (14 opened a new position, 16 added to an existing one), while 22 reduced or exited (3 trimmed, 19 sold completely) — a 58% buyer ratio, indicating a slight buying edge. Net fund flow last quarter: -5 funds (more exits than new entries). Total institutional holders: 56.

Hedge Fund Ownership: ONCY

How many hedge funds hold ONCY — quarterly history vs. share price
Quarterly hedge fund ownership of ONCY vs. share price

Market Analysis: ONCY

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ONCY

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy ONCOLYTICS BIOTECH INC (ONCY) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much ONCY has moved relative to its sector benchmark (XLV) since the 2026 Q1 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End March 31, 2026 · 67d ago
ONCY
-1.2%
XLV
+3.7%

ONCY outperformed XLV by -4.9% since March 31, 2026.

Since 13F Filing Date May 15, 2026 · 22d ago
ONCY
-6.7%
XLV
+4.8%

Since the filing became public, ONCY outperformed XLV by -11.5% .

Interpretation: The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference. Learn more →

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

4 top-rated funds 0 high-conviction
Consensus
3.0
/ 10
breadth
×
Elite
0.0
/ 10
conviction
Hedge Fund Positioning: ONCY
55 + Investors

Track Smart Money conviction in ONCY. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q1) Prior (2025 Q4) Change
Funds Holding 55 61 -9.84%
13F Shares 3M 3M 7.06%
Total Value $3M $2M 3.96%
New Positions 13 13 -
Increased Positions 16 9 +7
Closed Positions 19 8 +11
Reduced Positions 3 5 -2
Total Calls 0 0 -
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ONCY

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

55 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ONCY. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of ONCY — 2026 Q1 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Sandbox Financial Partners, LLC 0.10% 400,000 $340K
2 SEEDS INVESTOR LLC 0.04% 258,306 $263K
3 Ball & Co Wealth Management Inc. 0.03% 38,253
4 DOLIVER ADVISORS, LP 0.02% 100,000 $85K
5 SECURITY NATIONAL BANK OF SIOUX CITY IOWA /IA/ 0.02% 33,255 $28K
6 Everhart Financial Group, Inc. 0.01% 138,161 $117K
7 Vantage Point Financial LLC 0.01% 29,744 $25K
8 HEADINVEST, LLC 0.01% 44,700 $38K
9 SeaCrest Wealth Management, LLC 0.00% 32,000 $27K
10 TWO SIGMA SECURITIES, LLC 0.00% 25,627 $22K
11 PROFESSIONAL ADVISORY SERVICES INC 0.00% 20,000
12 PFG Investments, LLC 0.00% 52,900 $45K
13 TOCQUEVILLE ASSET MANAGEMENT L.P. 0.00% 149,000 $126K
14 XTX Topco Ltd 0.00% 109,758 $93K
15 RENAISSANCE TECHNOLOGIES LLC 0.00% 715,838 $608K
16 Cedar Mountain Advisors, LLC 0.00% 5,651 $5K
17 Activest Wealth Management 0.00% 5,000 $4K
18 Ausdal Financial Partners, Inc. 0.00% 12,000 $10K
19 AlphaCore Capital LLC 0.00% 12,500 $11K
20 Crestwood Advisors Group, LLC 0.00% 10,000 $8K
21 Larson Financial Group LLC 0.00% 5,000 $4K
22 Kingsview Wealth Management, LLC 0.00% 11,210 $10K
23 Federation des caisses Desjardins du Quebec 0.00% 36,499 $31K
24 Axiom Investment Management LLC 0.00% 150
25 CIBC WORLD MARKET INC. 0.00% 60,303 $51K
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — ONCOLYTICS BIOTECH INC (ONCY)

What does the Smart Money Trend signal show for ONCY?

Selling streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds reduced or closed their ONCY positions than added to them. Sustained institutional selling is a meaningful warning sign — these are professionals with deep research teams collectively deciding to exit.

What is the institutional breadth score for ONCY?

Slight buying edge — 58% buying: Last quarter: 30 funds bought or added vs 22 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for ONCY holders?

Smaller funds dominant — 17% AUM from top-100: 14 of 56 holders rank in the top 100 by AUM, but together hold only 17% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held ONCY?

41% of holders stayed for 2+ years: 23 out of 56 hedge funds have held ONCY for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy ONCOLYTICS BIOTECH INC (ONCY) following the 2026 Q1 hedge fund 13F filings?

As of today, ONCY has moved -6.7% since the 2026 Q1 13F filing date (May 15, 2026), compared to +4.8% for the XLV sector ETF — an outperformance of -11.5%. Since the quarter end (March 31, 2026), ONCY has gained -1.2% vs +3.7% for XLV. The stock is tracking its sector benchmark closely. The signal remains fresh and the entry point is still near the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →